For some men with prostate cancer, a genetic biomarker test called Decipher may help predict whether the cancer will spread to other parts of the body. The test could help determine whether hormone therapy, which can cause distressing side effects, is needed.
Watch an interactive conversation to get to know new NCI Director, Dr. Kimryn Rathmell, and hear her answers to some live questions about the future…
Sharon Savage, DCEG Clinical Director, describes the new, modern infrastructure for Family Studies conducted by the Clinical Genetics Branch. CHARMS is an interactive patient- and…
Treatment with Lu 177-dotatate (Lutathera) and octreotide (Sandostatin) shrank tumors in people with advanced neuroendocrine tumors, a clinical trial found.
A fact sheet that summarizes the evidence linking overweight and obesity to the risk of various cancers and discusses how obesity affects cancer survivors.
Black and Hispanic patients nearing the end of life are less likely than White patients to get needed opioid medications for cancer pain.
Learn more about the inter-disciplinary field “data science” and its relationship with cancer research.
NCI SBIR Director Michael Weingarten and Rukiyah Van Dross-Anderson, Founder and CEO of SBIR-funded Claradele Pharmaceuticals discuss the journey from postdoc to biotech startup and…
The Cancer Currents blog provides news and research updates from the National Cancer Institute.
Skin cancer prevention approaches include avoiding risk factors like ultraviolet radiation that comes from the sun, sun lamps, and tanning beds. Learn more about the…
Suggested questions for patients to ask their doctors when they learn they have cancer and want to know what to expect next.
